keyword
MENU ▼
Read by QxMD icon Read
search

Thrombo prophylaxis

keyword
https://www.readbyqxmd.com/read/27789264/early-ambulation-and-prevention-of-post-operative-thrombo-embolic-risk
#1
P Talec, S Gaujoux, C M Samama
The prevention of post-operative risk of venous thrombo-embolism (VTE) is of fundamental importance, but preventive methods have progressed with the introduction of direct oral anticoagulants (DOAC), the development of ambulatory surgery and enhanced recovery programs (ERP) after surgery. Surgery is, inherently a trigger for venous thrombo-embolic disease, as is prolonged immobilization. However, the risk of VTE is very low following ambulatory surgery, especially in this selected population. ERP, consists of a set of measures to optimize the patient's peri-operative management while reducing length of stay, costs and morbidity and mortality; one measure is the encouragement of early ambulation...
October 24, 2016: Journal of Visceral Surgery
https://www.readbyqxmd.com/read/27761572/the-saudi-clinical-practice-guideline-for-the-prophylaxis-of-venous-thromboembolism-in-medical-and-critically-ill-patients
#2
Fahad M Al-Hameed, Hasan M Al-Dorzi, Mohamed A Abdelaal, Ali Alaklabi, Ebtisam Bakhsh, Yousef A Alomi, Mohammad Al Baik, Salah Aldahan, Holger Schünemann, Jan Brozek, Wojtek Wiercioch, Andrea J Darzi, Reem Waziry, Elie A Akl
Venous thromboembolism (VTE) acquired during hospitalization is common, yet preventable by the proper implementation of thromboprophylaxis which remains to be underutilized worldwide. As a result of an initiative by the Saudi Ministry of Health to improve medical practices in the country, an expert panel led by the Saudi Association for Venous Thrombo Embolism (SAVTE; a subsidiary of the Saudi Thoracic Society) with the methodological guidance of the McMaster University Guideline working group, produced this clinical practice guideline to assist healthcare providers in VTE prevention...
November 2016: Saudi Medical Journal
https://www.readbyqxmd.com/read/27634971/venous-thrombotic-events-in-patients-admitted-to-a-tuberculosis-centre
#3
J F Borjas-Howard, W F W Bierman, K Meijer, T S van der Werf, Y I G V Tichelaar
BACKGROUND: Considering the relationship between inflammation and thrombosis, patients with tuberculosis (TB) patients might be at high risk of venous thrombosis. AIM: To evaluate the risk of venous thromboembolism in patients admitted to the Beatrixoord Tuberculosis Centre (BTBC), a tertiary centre for TB. We specifically explored which cofactors elevate the risk of venous thrombosis (VTE), and whether the timing of venous thrombotic events would justify extended primary prophylaxis...
September 10, 2016: QJM: Monthly Journal of the Association of Physicians
https://www.readbyqxmd.com/read/27633687/an-analysis-of-deep-vein-thrombosis-in-burn-patients-part-ii-a-randomized-and-controlled-study-of-thrombo-prophylaxis-with-low-molecular-weight-heparin
#4
Rajeev B Ahuja, Priya Bansal, Gaurav S Pradhan, Manju Subberwal
INTRODUCTION: Morbidity and mortality from venous thrombo-embolism (VTE) remains a significant problem for trauma and medical patients and there are established guidelines for prophylaxis in these patients. However, the efficacy and safety of VTE prophylaxis in thermally injured patients continue to be elusive as it has never been studied in a prospective, randomized fashion. Selective use of VTE prophylaxis, for high risk patients, is practiced by some burn units even if objective evidence is lacking for majority of risk factors enunciated in burn patients...
September 12, 2016: Burns: Journal of the International Society for Burn Injuries
https://www.readbyqxmd.com/read/27581506/the-prophylaxis-of-venous-thromboembolism
#5
Albrecht Encke, Sylvia Haas, Ina Kopp
BACKGROUND: Venous thromboembolism (VTE) is the third most common cardiovascular condition, after myocardial infarction and stroke. Prophylactic measures in accordance with current guidelines can significantly reduce the risk of VTE and the associated morbidity and mortality. Until now, the German interdisciplinary, evidence- and consensus-based (S3) clinical practice guideline on VTE prophylaxis was based on a complete review of all pertinent literature available in MEDLINE up to January 2008...
August 8, 2016: Deutsches Ärzteblatt International
https://www.readbyqxmd.com/read/27555696/the-incidence-of-deep-venous-thrombosis-in-high-risk-indian-neurosurgical-patients-need-for-early-chemoprophylaxis
#6
Ajith John George, Shalini Nair, Jayanthi Chinnaiya Karthic, Mathew Joseph
INTRODUCTION: Deep venous thrombosis (DVT) is thought to be less common in Asians than in Caucasian population. The incidence of DVT in high-risk groups, especially the neurosurgical (NS) patients, has not been well studied. This leaves no firm basis for the start of early prophylactic anticoagulation within first 5 postoperative days in Indian NS patients. This is a prospective observational study to determine the early occurrence of DVT in the NS patients. PATIENTS AND METHODS: We screened 137 consecutive high-risk NS patients based on inclusion and exclusion criteria...
July 2016: Indian Journal of Critical Care Medicine
https://www.readbyqxmd.com/read/27274266/the-effects-of-timing-of-prophylaxis-type-of-anesthesia-and-use-of-mechanical-methods-on-outcome-in-major-orthopedic-surgery-subgroup-analyses-from-17-701-patients-in-the-xamos-study
#7
Sylvia Haas, Gerlind Holberg, Reinhold Kreutz, Michael Rud Lassen, Lorenzo Mantovani, Verena Haupt, Kai Vogtländer, Alexander Gg Turpie
PURPOSE: Real-world data on the use of rivaroxaban in the perioperative period in patients undergoing major orthopedic surgery are limited. Subsets of data from the Phase IV, non-interventional XAMOS study were analyzed to explore the potential influence of timing of the first thrombo prophylactic dose, type of anesthesia, and concomitant mechanical prophylaxis on clinical outcomes in patients undergoing major orthopedic surgery in routine clinical practice. PATIENTS AND METHODS: In XAMOS, 8,778 patients received rivaroxaban (10 mg once daily) and 8,635 received standard-of-care (SOC) pharmacological prophylaxis (safety population)...
2016: Vascular Health and Risk Management
https://www.readbyqxmd.com/read/27143726/fatal-pulmonary-embolism-following-elective-total-hip-arthroplasty-a-12-year-study
#8
E Bayley, S Brown, N S Bhamber, P W Howard
AIMS: The place of thromboprophylaxis in arthroplasty surgery remains controversial, with a challenging requirement to balance prevention of potentially fatal venous thrombo-embolism with minimising wound-related complications leading to deep infection. We compared the incidence of fatal pulmonary embolism in patients undergoing elective primary total hip arthroplasty (THA) between those receiving aspirin, warfarin and low molecular weight heparin (LMWH) for the chemical component of a multi-modal thromboprophylaxis regime...
May 2016: Bone & Joint Journal
https://www.readbyqxmd.com/read/27117597/current-status-and-future-prospects-for-the-treatment-of-antiphospholipid-syndrome
#9
Ahlam Al Marzooqi, Alessia Leone, Jamal Al Saleh, Munther Khamashta
Antiphospholipid syndrome (APS) is a prothrombotic disease characterized by thrombosis and pregnancy morbidity in the presence of antiphospholipid antibodies (apL). Management of thrombosis is based on long-term oral anticoagulation and patients with arterial events should be treated aggressively. Primary thrombo-prophylaxis is recommended in patients with systemic lupus erythromatosus (SLE) and obstetric APS. Obstetric APS care is based on high-risk management and treatment with aspirin and heparin. Possible future therapies include statins, hydroxychloroquine, rituximab, and new anticoagulant drugs...
September 2016: Expert Review of Clinical Immunology
https://www.readbyqxmd.com/read/26475410/prospective-evaluation-of-protein-c-and-factor-viii-in-prediction-of-cancer-associated-thrombosis
#10
A J Tafur, G Dale, M Cherry, J D Wren, A S Mansfield, P Comp, S Rathbun, J A Stoner
Venous thromboembolism (VTE) is a preventable disease, yet it is one of the leading causes of death among patients with cancer. Improving risk stratification mechanisms will allow us to personalize thrombo-prophylaxis strategies. We sought to evaluate Collagen and Thrombin Activated Platelets (COAT-platelets) as well as protein C and factor VIII as biomarkers predictive of cancer-associated thrombosis in a prospective cohort of patients with cancer. Protein C was selected as a candidate based on bioinformatics prediction...
December 2015: Thrombosis Research
https://www.readbyqxmd.com/read/26336014/prophylaxis-and-treatment-of-venous-thromboembolism-in-patients-with-cancer-the-saudi-clinical-practice-guideline
#11
Fahad Al-Hameed, Hasan M Al-Dorzi, Abdulkarim AlMomen, Farjah Algahtani, Hazzaa AlZahrani, Khalid AlSaleh, Mohammed AlSheef, Tarek Owaidah, Waleed Alhazzani, Ignacio Neumann, Wojtek Wiercioch, Jan Brozek, Holger Schünemann, Elie A Akl
BACKGROUND AND OBJECTIVES: Venous thromboembolism (VTE) is commonly encountered in the daily clinical practice. Cancer is an important VTE risk factor. Proper thromboprophylaxis is key to prevent VTE in patients with cancer, and proper treatment is essential to reduce VTE complications and adverse events associated with the therapy. DESIGN AND SETTINGS: As a result of an initiative of the Ministry of Health of Saudi Arabia, an expert panel led by the Saudi Association for Venous Thrombo-Embolism (a subsidiary of the Saudi Thoracic Society) and the Saudi Scientific Hematology Society with the methodological support of the McMaster University working group produced this clinical practice guideline to assist health care providers in evidence-based clinical decision-making for VTE prophylaxis and treatment in patients with cancer...
March 2015: Annals of Saudi Medicine
https://www.readbyqxmd.com/read/26261929/-prophylaxis-of-thromboembolism-in-atrial-fibrillation-new-oral-anticoagulants-and-left-atrial-appendage-closure
#12
REVIEW
Tobias Zeus, Malte Kelm, Christoph Bode
Thrombo-embolic prophylaxis is a key element within the therapy of atrial fibrillation/atrial flutter. Besides new oral anticoagulants the concept of left atrial appendage occlusion has approved to be a good alternative option, especially in patients with increased risk of bleeding.
August 2015: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/25912931/fondaparinux-in-pregnancy-could-it-be-a-safe-option-a-review-of-the-literature
#13
REVIEW
S De Carolis, E di Pasquo, E Rossi, G Del Sordo, A Buonomo, D Schiavino, A Lanzone, V De Stefano
During pregnancy thrombo-prophylaxis could be required in high risk women. If a severe allergic reaction to low-molecular-weight-heparin (LMWH) or a heparin-induced-thrombocytopenia (HIT) occurs, it's mandatory to stop the drug. Fondaparinux could be an effective option. In the present review, the maternal and pregnancy outcomes of 65 pregnancies in women using Fondaparinux were reported. It was well-tolerated and rate of pregnancy complications was similar to that observed in general population. Regarding congenital malformations, further studies are necessary to investigate the safety of the drug...
June 2015: Thrombosis Research
https://www.readbyqxmd.com/read/25708424/deep-venous-thrombosis-was-not-detected-after-total-knee-arthroplasty-in-japanese-patients-with-haemophilia
#14
H Takedani, K Ohnuma, J Hirose
Combined thrombo-prophylaxis with mechanical and pharmacological methods is recommended in patients undergoing total knee or hip arthroplasty. As patients with 'untreated inherited bleeding disorders such as haemophilia' are at risk of bleeding, no prophylaxis has been prescribed for these patients. However, a retrospective study reported subclinical deep venous thrombosis (DVT) in 10% of patients with haemophilia undergoing major orthopaedic surgery. In this study, we aimed to evaluate the risk of DVT after total knee arthroplasty (TKA)...
September 2015: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://www.readbyqxmd.com/read/25682456/patient-s-compliance-on-the-use-of-extended-low-molecular-weight-heparin-post-major-pelvic-surgeries-in-cancer-patients-at-king-hussein-cancer-center
#15
M Baba, M Al-Masri, M Salhab, M El-Ghanem
UNLABELLED: Effective Venous Thrombo-Embolism (VTE) prophylaxis is used in less than 50% of oncology patients despite its wide availability. Low molecular weight heparin (LMWH) as a daily injection is an essential tool for effective prophylaxis against deep vein thrombosis (DVT). Daily outpatient self-injection by the patients or their family members is common practice. The effectiveness of this measure depends on patient compliance. OBJECTIVE: The purpose of this study is to determine the degree of compliance and the factors that affect compliance to the extended out-patient use of prophylactic LMWH for 1 month after major abdominal/pelvic surgeries in cancer patients at King Hussein Cancer Center (KHCC)...
January 2015: Gulf Journal of Oncology
https://www.readbyqxmd.com/read/25648058/timing-of-symptomatic-pulmonary-embolism-with-warfarin-following-arthroplasty
#16
Javad Parvizi, Ronald Huang, Ibrahim J Raphael, Mitchell G Maltenfort, William V Arnold, Richard H Rothman
The purpose is to determine the incidence and timing of pulmonary embolism for patients receiving warfarin for thrombo-prophylaxis following total joint arthroplasty (TJA). Current guidelines for duration of prophylaxis are nonspecific. Chemical prophylaxis carries the risk of bleeding and associated periprosthetic joint infection. We retrospectively studied 26,415 primary and revision TJA cases performed at our institution between 2000 and 2010. The overall 90-day rate of symptomatic PE was 1.07%. Fatal PE rate was 0...
June 2015: Journal of Arthroplasty
https://www.readbyqxmd.com/read/25269021/dvt-surveillance-program-in-the-icu-analysis-of-cost-effectiveness
#17
Ajai K Malhotra, Stephanie R Goldberg, Laura McLay, Nancy R Martin, Luke G Wolfe, Mark M Levy, Vishal Khiatani, Todd C Borchers, Therese M Duane, Michel B Aboutanos, Rao R Ivatury
BACKGROUND: Venous Thrombo-embolism (VTE--Deep venous thrombosis (DVT) and/or pulmonary embolism (PE)--in traumatized patients causes significant morbidity and mortality. The current study evaluates the effectiveness of DVT surveillance in reducing PE, and performs a cost-effectiveness analysis. METHODS: All traumatized patients admitted to the adult ICU underwent twice weekly DVT surveillance by bilateral lower extremity venous Duplex examination (48-month surveillance period--SP)...
2014: PloS One
https://www.readbyqxmd.com/read/25209598/higher-risk-of-death-and-stroke-in-patients-with-persistent-vs-paroxysmal-atrial-fibrillation-results-from-the-rocket-af-trial
#18
RANDOMIZED CONTROLLED TRIAL
Benjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, Manesh R Patel, Günter Breithardt, Graeme J Hankey, Richard C Becker, Daniel E Singer, Jonathan L Halperin, Werner Hacke, Christopher C Nessel, Scott D Berkowitz, Kenneth W Mahaffey, Keith A A Fox, Robert M Califf, Jonathan P Piccini
AIM: Anticoagulation prophylaxis for stroke is recommended for at-risk patients with either persistent or paroxysmal atrial fibrillation (AF). We compared outcomes in patients with persistent vs. paroxysmal AF receiving oral anticoagulation. METHODS AND RESULTS: Patients randomized in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET-AF) trial (n = 14 264) were grouped by baseline AF category: paroxysmal or persistent...
February 1, 2015: European Heart Journal
https://www.readbyqxmd.com/read/25162954/low-molecular-weight-heparin-lmwh-for-primary-thrombo-prophylaxis-in-patients-with-solid-malignancies-systematic-review-and-meta-analysis
#19
REVIEW
Irit Ben-Aharon, Salomon M Stemmer, Leonard Leibovici, Ofer Shpilberg, Aaron Sulkes, Anat Gafter-Gvili
BACKGROUND: Patients receiving chemotherapy for cancer are at increased risk for venous thromboembolism (VTE). We performed a meta-analysis of all randomized controlled trials (RCTs) which evaluated low molecular weight heparin (LMWH) as primary prophylaxis in ambulatory patients with solid malignancies. METHODS: A comprehensive search was conducted until October 2013. Primary outcome was symptomatic VTE. Secondary outcomes were pulmonary embolism (PE), any VTE, deep vein thrombosis (DVT), mortality and adverse events...
September 2014: Acta Oncologica
https://www.readbyqxmd.com/read/24987238/thrombo-prophylaxis-in-acutely-ill-medical-and-critically-ill-patients
#20
REVIEW
Saurabh Saigal, Jai Prakash Sharma, Rajnish Joshi, Dinesh Kumar Singh
Thrombo-prophylaxis has been shown to reduce the incidence of pulmonary embolism (PE) and mortality in surgical patients. The purpose of this review is to find out the evidence-based clinical practice criteria of deep vein thrombosis (DVT) prophylaxis in acutely ill medical and critically ill patients. English-language randomized controlled trials, systematic reviews, and meta-analysis were included if they provided clinical outcomes and evaluated therapy with low-dose heparin or related agents compared with placebo, no treatment, or other active prophylaxis in the critically ill and medically ill population...
June 2014: Indian Journal of Critical Care Medicine
keyword
keyword
14806
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"